Pulse استكشاف nav.journalClub النقاشات الرائج الباحثون المجلات

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

الرئيسية استكشاف nav.journalClub الرائج

⌘+K

Research Paper | Synapse

April 1, 2026Open Access

View Full Paper

Correction: Bednarek et al. Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function. Diagnostics 2026, 16, 786

ABAnna BednarekSilesian Center for Heart Disease AOAleksander OwczarekMedical University of Silesia DDDominika DziadoszMedical University of Silesia

Key Points

To evaluate the effectiveness of serum osteoprotegerin as a biomarker for atherosclerosis in relation to kidney function.
Review of original data on serum osteoprotegerin levels
Analysis of the relationship between osteoprotegerin and atherosclerosis
Comparison of results across varying kidney function statuses
Confirmed that osteoprotegerin levels are not reliable indicators of atherosclerosis
Indicated that kidney function does not influence osteoprotegerin's role as a biomarker

Abstract

In the original publication ...

اسأل الذكاء الاصطناعي

Like

Bookmark

Share

View Full Paper

اسأل الذكاء الاصطناعي

Like

Bookmark

Share

View Full Paper

Cite This Study

Bednarek et al. (Mon,) studied this question.

synapsesocial.com/papers/69ccb59f16edfba7beb877e7 https://doi.org/https://doi.org/10.3390/diagnostics16071040